MEDIA RELEASE 19 May 2021
- Advancing medical solutions that protect the health of all Australians.
The National Pharmaceutical Services Association has welcomed the decision by Pfizer Australia to resume medicine distribution services through the Community Service Obligation (CSO) wholesaler model.
Pfizer has announced a return to the wholesaler model, ending the direct distribution previously conducted by DHL.
NPSA Chair and API Managing Director Richard Vincent said, “Today’s announcement is significant recognition of the capability of NPSA members. We have a proven track record of supporting medicine companies, pharmacies and consumers with reliable access 24 hours a day, seven days a week.”
NPSA is the peak industry body for medicine wholesalers API, National Pharmacies, Sigma and Symbion. Its mission is to advance medical solutions to protect the health of all Australians.
“The certainty of uninterrupted and equitable distribution of medicines and vaccines to all corners of Australia has never been more important.
“As an industry we have continued to invest in a state-of-the-art national network that is dedicated solely to protecting the health of all Australians. This sustained member investment in sophisticated distribution centres, technology and our people has meant we have been able to meet the extreme challenges of COVID-19, the bushfire and flood emergencies.
“We’ve stepped up to take a proactive role in managing medicines in difficult times and increased our liaison with stakeholders across the supply chain to provide solutions.
“We look forward to again supporting Pfizer to ensure its portfolio of innovative and off-patent medicines are efficiently and safely delivered to hospital pharmacies and more than 5,600 community pharmacies and their patients across Australia,” Mr Vincent said.
Contact: media@npsa.org.au